Literature DB >> 20948553

Developing vaccines to combat hookworm infection and intestinal schistosomiasis.

Peter J Hotez1, Jeffrey M Bethony, David J Diemert, Mark Pearson, Alex Loukas.   

Abstract

Hookworm infection and schistosomiasis rank among the most important health problems in developing countries. Both cause anaemia and malnutrition, and schistosomiasis also results in substantial intestinal, liver and genitourinary pathology. In sub-Saharan Africa and Brazil, co-infections with the hookworm, Necator americanus, and the intestinal schistosome, Schistosoma mansoni, are common. The development of vaccines for these infections could substantially reduce the global disability associated with these helminthiases. New genomic, proteomic, immunological and X-ray crystallographic data have led to the discovery of several promising candidate vaccine antigens. Here, we describe recent progress in this field and the rationale for vaccine development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20948553     DOI: 10.1038/nrmicro2438

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  138 in total

1.  Proteins exposed at the adult schistosome surface revealed by biotinylation.

Authors:  Simon Braschi; R Alan Wilson
Journal:  Mol Cell Proteomics       Date:  2005-11-03       Impact factor: 5.911

Review 2.  Industrial development and field use of the canine hookworm vaccine.

Authors:  T A Miller
Journal:  Adv Parasitol       Date:  1978       Impact factor: 3.870

3.  Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials.

Authors:  Gaddam Narsa Goud; Maria Elena Bottazzi; Bin Zhan; Susana Mendez; Vehid Deumic; Jordan Plieskatt; Sen Liu; Yan Wang; Lilian Bueno; Ricardo Fujiwara; Andre Samuel; So Yeong Ahn; Maneesha Solanki; Oluwatoyin A Asojo; Jin Wang; Jeffrey M Bethony; Alex Loukas; Michael Roy; Peter J Hotez
Journal:  Vaccine       Date:  2005-09-15       Impact factor: 3.641

Review 4.  Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy.

Authors:  R D Moore
Journal:  Semin Hematol       Date:  2000-10       Impact factor: 3.851

5.  Consequences of Schistosoma haematobium infection on the iron status of schoolchildren in Niger.

Authors:  A Prual; H Daouda; M Develoux; B Sellin; P Galan; S Hercberg
Journal:  Am J Trop Med Hyg       Date:  1992-09       Impact factor: 2.345

6.  Proteolytic degradation of hemoglobin in the intestine of the human hookworm Necator americanus.

Authors:  Najju Ranjit; Bin Zhan; Brett Hamilton; Deborah Stenzel; Jonathan Lowther; Mark Pearson; Jeffrey Gorman; Peter Hotez; Alex Loukas
Journal:  J Infect Dis       Date:  2009-03-15       Impact factor: 5.226

Review 7.  The unacknowledged impact of chronic schistosomiasis.

Authors:  Charles H King; Madeline Dangerfield-Cha
Journal:  Chronic Illn       Date:  2008-03

8.  Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs.

Authors:  Alex Loukas; Jeffrey M Bethony; Susana Mendez; Ricardo T Fujiwara; Gaddam Narsa Goud; Najju Ranjit; Bin Zhan; Karen Jones; Maria Elena Bottazzi; Peter J Hotez
Journal:  PLoS Med       Date:  2005-10-04       Impact factor: 11.069

9.  The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination.

Authors:  Peter J Hotez; Maria Elena Bottazzi; Carlos Franco-Paredes; Steven K Ault; Mirta Roses Periago
Journal:  PLoS Negl Trop Dis       Date:  2008-09-24

10.  Trick or treat: the role of vaccines in integrated schistosomiasis control.

Authors:  Robert Bergquist; Jürg Utzinger; Donald P McManus
Journal:  PLoS Negl Trop Dis       Date:  2008-06-25
View more
  108 in total

Review 1.  A history of hookworm vaccine development.

Authors:  Brent Schneider; Amar R Jariwala; Maria Victoria Periago; Maria Flávia Gazzinelli; Swaroop N Bose; Peter J Hotez; David J Diemert; Jeffrey M Bethony
Journal:  Hum Vaccin       Date:  2011-11-01

2.  Polymorphism associated with the Schistosoma mansoni tetraspanin-2 gene.

Authors:  Pauline M Cupit; Michelle L Steinauer; Bradley W Tonnessen; L Eric Agola; Joseph M Kinuthia; Ibrahim N Mwangi; Martin W Mutuku; Gerald M Mkoji; Eric S Loker; Charles Cunningham
Journal:  Int J Parasitol       Date:  2011-08-22       Impact factor: 3.981

3.  Specific humoral response of hosts with variable schistosomiasis susceptibility.

Authors:  Patrick Driguez; Hamish E G McWilliam; Soraya Gaze; David Piedrafita; Mark S Pearson; Rie Nakajima; Mary Duke; Angela Trieu; Denise L Doolan; Fernanda C Cardoso; Algis Jasinskas; Geoffrey N Gobert; Philip L Felgner; Alex Loukas; Els Meeusen; Donald P McManus
Journal:  Immunol Cell Biol       Date:  2015-06-05       Impact factor: 5.126

4.  Still hope for schistosomiasis vaccine.

Authors:  Alessandra Ricciardi; Momar Ndao
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Structure of a two-CAP-domain protein from the human hookworm parasite Necator americanus.

Authors:  Oluwatoyin A Asojo
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-04-07

6.  The medical biochemistry of poverty and neglect.

Authors:  Peter J Hotez
Journal:  Mol Med       Date:  2014-12-16       Impact factor: 6.354

Review 7.  Sm-p80-Based Schistosomiasis Vaccine: Preparation for Human Clinical Trials.

Authors:  Afzal A Siddiqui; Sabrina Z Siddiqui
Journal:  Trends Parasitol       Date:  2016-11-16

8.  The dynamic changes of CD3e-CD11c+ dendritic cells in spleens and bone marrow of mice infected with Schistosoma japonicum.

Authors:  Lin Chen; Qingzhou Chen; Wei Hou; Li He
Journal:  Parasitol Res       Date:  2017-02-10       Impact factor: 2.289

9.  Haematophagic Caenorhabditis elegans.

Authors:  Veeren M Chauhan; David I Pritchard
Journal:  Parasitology       Date:  2018-10-25       Impact factor: 3.234

10.  Oxadiazole 2-oxides are toxic to the human hookworm, Ancylostoma ceylanicum, however glutathione reductase is not the primary target.

Authors:  R S Treger; A G Cook; G Rai; D J Maloney; A Simeonov; A Jadhav; C J Thomas; D L Williams; M Cappello; J J Vermeire
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-05-18       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.